News

Investor Alert: Taking Action Against Easterly ROCMuni Fund Losses

Investor Alert: Taking Action Against Easterly ROCMuni Fund Losses

Investors Take Notice: Class Action Lawsuit Against Easterly ROCMuni Fund

Investors who purchased shares of the Easterly ROCMuni High Income Municipal Bond Fund (NYSE: RMJAX; RMHVX; RMHIX) should be aware of a class action lawsuit that is gaining attention. This legal action is open to those who acquired shares between certain dates and faced significant financial losses.

Details of the Class Action Lawsuit

The lawsuit, formally titled Victorson v. James Alpha Funds Trust d/b/a Easterly Funds Trust, No. 25-cv-06028 (S.D.N.Y.), puts a spotlight on serious allegations regarding the fund's management. Plaintiffs claim that during the Class Period, the fund's management made substantial misrepresentations regarding the value and stability of its portfolio.

Key Allegations Against the Fund

The class action lawsuit puts forth several allegations regarding the fund's operations. Notably, it is claimed that the Easterly ROCMuni Fund reported inflated prices for its assets, which did not truly represent their fair market value. This misinformation led to a misrepresentation of the fund's net asset value (NAV) and potential risks associated with its investment strategies.

Specifically, the allegations state that the fund utilized a faulty pricing methodology that resulted in artificial inflation of its NAV. Furthermore, it was revealed that the fund had more illiquid assets than were disclosed, increasing its risk profile significantly.

Impact of Recent Market Movements

In a startling turn of events on June 13, 2025, the fund marked down its shares by 30%. For instance, RMHIX saw its NAV drop from $6.15 to $4.33 in just one day. Similarly, RMHVX and RMJAX experienced similar declines. The legal action follows these abrupt losses, which have left many investors financially impacted.

Understanding the Role of a Lead Plaintiff

The Private Securities Litigation Reform Act of 1995 allows any investor purchasing shares during the specified period to be considered for the position of lead plaintiff in the lawsuit. The chosen lead plaintiff will represent the interests of all investors involved.

Who Can Be a Lead Plaintiff?

To qualify as a lead plaintiff, an investor must demonstrate that they possess the greatest financial interest in the issue at hand and that their claims are typical of those of the entire class. Notably, becoming a lead plaintiff does not impact one’s ability to benefit from a potential settlement or recovery associated with the class action.

About Robbins Geller Rudman & Dowd LLP

Robbins Geller Rudman & Dowd LLP stands out as a leading law firm focused on securities fraud and shareholder litigation. The firm has built a reputable standing, having secured substantial recoveries for investors in securities-related class actions, making them an experienced choice for representation in this lawsuit.

With a dedicated team of attorneys, Robbins Geller has a proven history of winning significant settlements on behalf of investors. Their extensive experience in handling complex legal matters positions them as effective advocates for those affected by the challenges faced by the Easterly ROCMuni Fund.

Frequently Asked Questions

What is the Easterly ROCMuni Fund?

The Easterly ROCMuni Fund is a mutual fund that aims to provide high-yield returns by investing in high-yield municipal bonds.

Why is there a class action lawsuit against the fund?

The lawsuit alleges that the fund's management misrepresented asset values and risks, which led to significant financial losses for investors.

Who can join the class action lawsuit?

Investors who purchased shares during the specified class period and experienced losses can seek to join the class action.

What does being a lead plaintiff involve?

A lead plaintiff represents the interests of all class members and directs the lawsuit, but you do not have to be a lead plaintiff to benefit from potential recoveries.

How can I contact Robbins Geller for more information?

You can reach out to them by phone at 800-449-4900 for inquiries regarding the lawsuit or your investment situation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

United Apartment Group's Leadership Revamp Signals Growth

Updated Category News Views 7

A Bold Leadership Expansion Big moves are afoot at United Apartment Group (UAG). They're not just refilling some roles here; they're rebooting their lineup with serious hitters—Woody Stone and Lenzie O’Connor are now steering the ship on business development and client services, eager to drive the company to new heights. Woody Stone: Fueled by Experience Stone isn't...

Continue Reading
Retirement Security Faces Global Headwinds in 2026

Updated Category News Views 10

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 4

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Quantum Sky's Strategic Leadership Overhaul Targets Growth

Updated Category News Views 5

Executive Shake-Up Aims for Stronger Federal Market Alignment Buckle up, folks—there's some major chess-piecing happening at Quantum Sky. They've just named not one or two, but three executive bigwigs to head up their core business groups. This isn’t just some ceremonial reshuffle. Nah, it’s bigger. They're redefining how they tackle the Department of War, Intel &...

Continue Reading
Amy Wilson Joins ITSA Board: A New Era for UBI?

Updated Category News Views 5

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 4

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Apex Dental's Growth Shines in Inc. 5000 Ranking

Updated Category News Views 5

Another Year, Another Milestone for Apex Dental Let's talk about steady growth. Apex Dental Partners has made it onto the Inc. 5000 list for the eighth straight year, landing at No. 3,850. Quite a feat, considering this list only features America's fastest-growing private companies. Apex isn't just maintaining its position out of sheer luck. Revenue shot up by 67% over...

Continue Reading
Kansas City Current's Grand Playoff Push in 2026

Updated Category News Views 9

A Celebration of Fans and Momentum Some things are bigger than just a match. The Kansas City Current’s event, 'One Current 2026: Bigger Home. Bigger Future.' ain't just another day on the pitch. This is about expanding a vision that has the whole town buzzing. On Sunday, October 25, the buzzhits fever pitch as CPKC Stadium rolls out the biggest event in its...

Continue Reading
Alex Jones Returns to Austin: New Studio, New Plans

Updated Category News Views 3

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 5

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading

Top 5 Most Recently Viewed Articles

Encouraging Clinical Trial Outcomes for IDEAYA Biosciences

Updated Category News Views 214

IDEAYA Biosciences Shares Phase 2 Trial Results IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a frontrunner in precision medicine for oncology, has announced encouraging interim findings from its Phase 2 clinical trial involving darovasertib, a drug aimed at treating neoadjuvant uveal melanoma (UM). The results show a significant tumor shrinkage rate and high preservation of...

Continue Reading
Celebrating ATS's Recognition Among Top Sales Companies for 2025

Updated Category News Views 120

ATS Achieves Prestigious Listing in Sales Excellence Advanced Technology Services, Inc. (ATS) has been recognized on Selling Power's esteemed annual list of the 60 Best Companies to Sell For. This accolade highlights the organization's commitment to excellence in sales performance and foundational investment in its team. Investing in People for Success Matthew Conway,...

Continue Reading
Understanding Super Micro Computer's Recent Stock Movement

Updated Category News Views 293

Super Micro Computer (NASDAQ: SMCI) took a hefty hit on the trading floor, tumbling 12.2% by day’s end after reports surfaced about an impending investigation by the Department of Justice (DoJ). At one moment, it plunged even deeper, down as much as 18.6%, sending ripples of anxiety through traders and market analysts alike. The DoJ's scrutiny seems to revolve around...

Continue Reading
Ameren Corp Reports Promising Second Quarter 2025 Earnings

Updated Category News Views 119

Ameren Corporation's Second Quarter Performance Ameren Corporation (AEE) shared commendable financial results for its second quarter. The company reported a net income attributable to common shareholders of $275 million, translating to $1.01 per diluted share. This represents an increase from last year's earnings of $258 million, or $0.97 per diluted share. Revenue and...

Continue Reading
Discovering Your Biological Age with Unaging's New Tool

Updated Category News Views 117

Unlocking the Secrets of Your Biology with the New Calculator Unaging, a pioneering platform dedicated to the realms of health and longevity, has revealed its latest innovation: the Biological Age Calculator 2.0. This advanced tool allows individuals to dig deeper into their health, moving beyond mere chronological age to discover their actual biological state. Why...

Continue Reading